MIT's Dual-Adjuvant HIV Vaccine
This is a news story, published by New Atlas, that relates primarily to MIT news.
News about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsNew Atlas news
For more news from New Atlas, you can click here:
more news from New AtlasAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
adjuvant vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest strong vaccines news, adjuvant formulations news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
synthetic adjuvantNew Atlas
•Health
Health
MIT's one-shot vaccine could deliver robust protection from HIV

82% Informative
MIT 's one -shot vaccine could deliver robust protection from HIV.
Researchers combined two adjuvants to elicit a significantly better immune response than a vaccine with just one of them.
The new approach caused the dual-adjuvant vaccine to accumulate in the mice's lymph nodes and stay there for a month , during which time their immune systems effectively built up plenty of antibodies against the HIV protein.
This approach could come in handy for formulating protein-based vaccines to protect against influenza and SARS-CoV-2.
VR Score
80
Informative language
79
Neutral language
34
Article tone
formal
Language
English
Language complexity
67
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Affiliate links
no affiliate links